Morningstar reiterates $250 FVE on Tesla (TSLA); says stock is 'undervalued'
- Wall Street edges lower ahead of Powell comments
- CVS Health (CVS) to buy Oak Street Health (OSH) for $10.5 billion - WSJ
- Biden expected to call for 400% increase in buyback tax
- Pinterest (PINS) erases bulk of after-hours losses after positive earnings call, analysts raise numbers
- Activision Blizzard (ATVI): Call of Duty strength fuel earnings beat
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Shares of Tesla (NASDAQ: TSLA) are down 1.57% in mid-day trading on Friday after Morningstar released a report reiterating a $250 fair value estimate on the company. Analyst Seth Goldstein views the shares as currently undervalued, with the stock trading in four-star territory.
Goldstein wrote, “We think the market is concerned that a near-term global economic slowdown will hurt demand for Tesla's cars. However, given the company's relatively small volume base of 1.2 million deliveries on a trailing 12-months basis, we think there is likely still room to grow considerably over the next couple of years even in an economic slowdown.”
Morningstar estimates that Tesla will deliver nearly 1.4 million and 2.1 million vehicles in 2022 and 2023, respectively. Given that all four of the company's models target the luxury auto market, Goldstein thinks the automaker’s deliveries are less likely to be significantly affected in an economic slowdown, as luxury goods in general tend to see demand hold up better.
By Michael Elkins | [email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital builds on confidence as Tesla (TSLA) shows they can spur demand growth
- Active options: TSLA BBBY AMZN AAPL PINS MSFT AMC NVDA
- Active options: TSLA BBBY AAPL AMC AMZN META NVDA GOOGL SNAP
Create E-mail Alert Related CategoriesAnalyst Comments, Hot List
Related EntitiesMorningstar, Inc., Tesla, Michael Elkins
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!